Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Troponin T | 6 | 2017 | 52 | 2.850 |
Why?
|
| Muscle, Skeletal | 13 | 2018 | 493 | 2.500 |
Why?
|
| Aging | 7 | 2017 | 930 | 1.600 |
Why?
|
| Calcium Channels, L-Type | 3 | 2016 | 54 | 1.340 |
Why?
|
| MicroRNAs | 3 | 2017 | 171 | 1.200 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2017 | 28 | 0.870 |
Why?
|
| Calpain | 2 | 2017 | 13 | 0.810 |
Why?
|
| Cell Nucleus | 4 | 2016 | 112 | 0.800 |
Why?
|
| Exercise Therapy | 2 | 2017 | 222 | 0.690 |
Why?
|
| Muscle Denervation | 1 | 2017 | 27 | 0.690 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 492 | 0.690 |
Why?
|
| Gait | 1 | 2017 | 92 | 0.660 |
Why?
|
| Excitation Contraction Coupling | 1 | 2015 | 10 | 0.610 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2015 | 101 | 0.600 |
Why?
|
| Troponin | 1 | 2015 | 79 | 0.580 |
Why?
|
| Calcium Channels | 1 | 2015 | 53 | 0.580 |
Why?
|
| Mice | 13 | 2018 | 2366 | 0.560 |
Why?
|
| Resistance Training | 1 | 2015 | 70 | 0.550 |
Why?
|
| Knee Joint | 1 | 2015 | 98 | 0.540 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 54 | 0.540 |
Why?
|
| Apoptosis | 2 | 2013 | 369 | 0.530 |
Why?
|
| Pericytes | 4 | 2014 | 26 | 0.520 |
Why?
|
| Muscle Cells | 1 | 2013 | 9 | 0.520 |
Why?
|
| Cell Line | 4 | 2016 | 432 | 0.500 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 130 | 0.490 |
Why?
|
| Animals | 18 | 2018 | 7552 | 0.480 |
Why?
|
| RNA, Messenger | 1 | 2013 | 544 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 704 | 0.390 |
Why?
|
| Obesity | 1 | 2017 | 1104 | 0.380 |
Why?
|
| Laryngeal Muscles | 3 | 2014 | 16 | 0.380 |
Why?
|
| Neuromuscular Junction | 3 | 2018 | 63 | 0.330 |
Why?
|
| Sulfonamides | 2 | 2017 | 72 | 0.320 |
Why?
|
| Muscle Contraction | 2 | 2017 | 111 | 0.310 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 141 | 0.290 |
Why?
|
| Acute Lung Injury | 2 | 2015 | 30 | 0.280 |
Why?
|
| Muscular Atrophy | 4 | 2018 | 69 | 0.240 |
Why?
|
| Flow Cytometry | 2 | 2013 | 173 | 0.240 |
Why?
|
| Antigens | 4 | 2014 | 27 | 0.230 |
Why?
|
| Proteoglycans | 4 | 2014 | 33 | 0.220 |
Why?
|
| Male | 9 | 2017 | 18658 | 0.220 |
Why?
|
| Exercise | 2 | 2017 | 575 | 0.220 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 109 | 0.200 |
Why?
|
| Female | 7 | 2017 | 18970 | 0.190 |
Why?
|
| Receptors, Cholinergic | 1 | 2018 | 22 | 0.190 |
Why?
|
| Sympathetic Nervous System | 1 | 2018 | 32 | 0.190 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2016 | 21 | 0.190 |
Why?
|
| Acetylcholine | 1 | 2018 | 38 | 0.190 |
Why?
|
| Physical Conditioning, Animal | 2 | 2017 | 39 | 0.190 |
Why?
|
| Wasting Syndrome | 2 | 2015 | 14 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 224 | 0.180 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 5 | 0.180 |
Why?
|
| Lipolysis | 1 | 2017 | 15 | 0.180 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2017 | 7 | 0.180 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 7 | 0.170 |
Why?
|
| Cell Differentiation | 3 | 2015 | 425 | 0.170 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 10 | 0.170 |
Why?
|
| Gene Expression | 3 | 2017 | 340 | 0.170 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 39 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 85 | 0.170 |
Why?
|
| Muscle Proteins | 2 | 2015 | 63 | 0.170 |
Why?
|
| Aged | 3 | 2017 | 10068 | 0.170 |
Why?
|
| Humans | 8 | 2017 | 29292 | 0.170 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 15 | 0.160 |
Why?
|
| Muscle Fatigue | 1 | 2016 | 11 | 0.160 |
Why?
|
| Isometric Contraction | 1 | 2016 | 23 | 0.160 |
Why?
|
| Protein Stability | 1 | 2016 | 27 | 0.160 |
Why?
|
| Action Potentials | 1 | 2017 | 166 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 75 | 0.160 |
Why?
|
| Mice, Transgenic | 5 | 2014 | 241 | 0.150 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 3924 | 0.150 |
Why?
|
| Protein Binding | 1 | 2016 | 196 | 0.150 |
Why?
|
| Gene Library | 1 | 2015 | 11 | 0.150 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 11 | 0.150 |
Why?
|
| Alternative Splicing | 1 | 2015 | 35 | 0.150 |
Why?
|
| Myogenin | 1 | 2014 | 4 | 0.140 |
Why?
|
| Neutrophils | 1 | 2015 | 105 | 0.140 |
Why?
|
| RNA Splicing | 1 | 2013 | 10 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 64 | 0.140 |
Why?
|
| Myoblasts | 1 | 2014 | 38 | 0.140 |
Why?
|
| Weight Loss | 1 | 2017 | 420 | 0.140 |
Why?
|
| Muscle Strength | 1 | 2015 | 134 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 91 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 176 | 0.130 |
Why?
|
| Ischemia | 1 | 2014 | 88 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 105 | 0.130 |
Why?
|
| Leucine Zippers | 1 | 2013 | 3 | 0.130 |
Why?
|
| Nuclear Localization Signals | 1 | 2013 | 4 | 0.130 |
Why?
|
| Annexin A5 | 1 | 2013 | 7 | 0.130 |
Why?
|
| Adipogenesis | 1 | 2013 | 30 | 0.130 |
Why?
|
| Age Factors | 1 | 2017 | 1185 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 48 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 68 | 0.130 |
Why?
|
| Calcium | 1 | 2015 | 322 | 0.130 |
Why?
|
| Body Composition | 1 | 2015 | 366 | 0.130 |
Why?
|
| Levodopa | 1 | 2012 | 12 | 0.120 |
Why?
|
| Biopsy | 1 | 2013 | 251 | 0.120 |
Why?
|
| Reflex | 1 | 2012 | 15 | 0.120 |
Why?
|
| Neuroglia | 1 | 2012 | 33 | 0.120 |
Why?
|
| Dopamine Agents | 1 | 2012 | 19 | 0.120 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 30 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2014 | 151 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 35 | 0.120 |
Why?
|
| Electroporation | 1 | 2011 | 14 | 0.120 |
Why?
|
| Extremities | 1 | 2012 | 39 | 0.120 |
Why?
|
| Immunoblotting | 1 | 2011 | 56 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 82 | 0.120 |
Why?
|
| Staining and Labeling | 1 | 2011 | 58 | 0.120 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 100 | 0.110 |
Why?
|
| Regeneration | 1 | 2013 | 164 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2014 | 793 | 0.110 |
Why?
|
| Luminescent Proteins | 3 | 2014 | 21 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 114 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2198 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 614 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 100 | 0.070 |
Why?
|
| Cell Lineage | 2 | 2013 | 67 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 2 | 2012 | 9 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2014 | 293 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1040 | 0.050 |
Why?
|
| Time Factors | 2 | 2015 | 2105 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2018 | 52 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2017 | 10 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 9 | 0.040 |
Why?
|
| Salivary Glands | 1 | 2017 | 14 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 36 | 0.040 |
Why?
|
| Rats | 2 | 2012 | 1750 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2017 | 145 | 0.040 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 8 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 20 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 25 | 0.040 |
Why?
|
| Chemokines | 1 | 2015 | 34 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2015 | 56 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 715 | 0.040 |
Why?
|
| Chromatin | 1 | 2014 | 16 | 0.040 |
Why?
|
| Actins | 1 | 2014 | 53 | 0.030 |
Why?
|
| Vocal Cords | 1 | 2014 | 8 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 75 | 0.030 |
Why?
|
| Hindlimb | 1 | 2014 | 57 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 2 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 5 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2013 | 36 | 0.030 |
Why?
|
| Fibrosis | 1 | 2013 | 117 | 0.030 |
Why?
|
| Laryngeal Nerves | 1 | 2012 | 4 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2012 | 12 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2014 | 429 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2012 | 135 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 85 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 24 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 61 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 137 | 0.030 |
Why?
|
| Motor Activity | 1 | 2015 | 332 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 666 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 90 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2013 | 173 | 0.030 |
Why?
|
| Reaction Time | 1 | 2012 | 122 | 0.030 |
Why?
|
| Proteomics | 1 | 2012 | 78 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 524 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 209 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 813 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3173 | 0.020 |
Why?
|